Nembutal (Pentobarbital): Side Effects, Uses, Dosage

Nembutal, whose active ingredient is Pentobarbital, is a short-acting
barbiturate that acts as a central nervous system (CNS) depressant. It
enhances the activity of gamma-aminobutyric acid (GABA), an inhibitory
neurotransmitter in the brain, leading to sedation, hypnosis, and, at
higher doses, anesthesia. Historically, it has been used for the short-term
treatment of severe insomnia, for preoperative sedation, and as an
anticonvulsant in certain clinical situations. However, due to its high
potential for dependence, overdose, and respiratory depression, its use in
routine clinical practice has significantly declined and is now highly
restricted in many countries.

From a pharmacological perspective, pentobarbital reduces neuronal
excitability by increasing the duration of chloride channel opening at the
GABA-A receptor. This results in decreased cortical activity, producing
calming, sedative, and sleep-inducing effects. Onset of action is rapid
when administered intravenously and somewhat slower when taken orally, with
a relatively short duration of effect compared to long-acting barbiturates.
The drug is metabolized primarily in the liver and excreted via the
kidneys.

Clinically, Nembutal may be indicated for sedation prior to surgical or
diagnostic procedures, emergency control of acute seizures, and, in
veterinary medicine, for euthanasia. In human medicine, its use is now
limited and tightly controlled, often replaced by safer alternatives such
as benzodiazepines or non-barbiturate sedatives.

Common side effects include drowsiness, dizziness, impaired coordination,
headache, nausea, and confusion. Patients may also experience paradoxical
reactions such as agitation or hyperactivity, particularly in elderly
individuals or those with underlying psychiatric conditions. More serious
adverse effects include respiratory depression, hypotension, bradycardia,
and impaired cognitive function. At higher doses, the drug can suppress the
respiratory drive, leading to hypoxia, coma, and death, especially when
combined with other CNS depressants such as alcohol or opioids.

The dosage of pentobarbital varies depending on the indication, route of
administration, and patient-specific factors such as age, weight, and
comorbidities. For sedation, lower doses are typically used, while higher
doses may be administered under strict medical supervision for anesthesia
or seizure control. Because of its narrow therapeutic index, dosing must be
carefully monitored to avoid toxicity.

Nembutal carries a high risk of tolerance, physical dependence, and
withdrawal symptoms, which may include anxiety, tremors, insomnia,
seizures, and, in severe cases, delirium or death. For this reason, it is
classified as a controlled substance in many jurisdictions, and its
prescription is strictly regulated. It is contraindicated in patients with
a history of barbiturate hypersensitivity, severe respiratory disease,
porphyria, or significant liver impairment.

In summary, pentobarbital is a potent CNS depressant with well-established
sedative and anticonvulsant properties, but its clinical use is limited
today due to safety concerns, risk of abuse, and availability of safer
alternatives. Careful medical supervision is essential whenever this
medication is used.

Minimum Order: 10 grams

Click to Enlarge